Abstract
BACKGROUND:
Animal studies have shown that nitric oxide is involved in delayed ischemic preconditioning.
OBJECTIVES:
To determine whether plasma nitrates and nitrites (NOx−, as measure of nitric oxide) are modified by two consecutive effort tests and whether these changes translate into clinical improvement
METHODS:
Twenty-two patients with ischemic heart disease each performed two effort tests at 24-h intervals. Plasma NOx− level was determined and compared before and after both stress tests. Peak effort, double product at peak effort and maximal ST segment depression were considered clinical endpoints and were compared between the two tests.
RESULTS:
Plasma NOx−increased slightly after the first exercise test compared with pretest value (17.05±1.6 μmol/mL versus 15.38±1.4 μmol/mL). In turn, after the second test there was a significant rise in NOx− level (23.65±2.2 μmol/mL versus 15.10±1.3 μmol/mL, P<0.03). The pretest values were almost identical between the two tests. Peak effort and double product at peak effort remained unchanged between the two tests. Although ischemic stress was the same, ST depression was significantly lower (P<0.01) for the second test (0.85±0.06 mm versus 1.73±0.16 mm).
CONCLUSION:
Our study shows an increased plasma NOx−level after the second of two consecutive exercise stress tests at 24-h intervals, along with a decrease of electrocardiographic consequences of approximately the same ischemic stress. These findings are consistent with experimental data in animals, which point to nitric oxide as a trigger and effector of ischemic preconditioning.
Keywords: Delayed preconditioning, Exercise, Nitrate, Nitric oxide, Nitrite
Delayed ischemic preconditioning is generally considered the mechanism of the favourable effect of a previous angina on outcome in acute myocardial infarction patients (1–3). It could also be the cause of decreased maximal ST depression under a similar ischemic stress during successive exercise stress testing (4,5) or of the increase in myocardial workload at which similar effects (eg, the same ST depression or angina) occur.
The mechanism of delayed preconditioning seems to involve nitric oxide (NO) as both a trigger and a mediator of the phenomenon (6–8). It was shown that a first ischemic episode increases NO production via constitutive endothelial nitric oxide synthase (eNOS). NO is one of the triggers for transcription of inducible nitric oxide synthase (iNOS) resulting in greater NO production during a second ischemic episode (24 h later), which mediates the protective effect.
Such an increase in NO production during the second ischemic episode was not shown in humans until now.
The purpose of our study was to investigate NO production before and after two consecutive exercise stress tests at 24-h intervals.
METHODS
The study involved 22 patients with ischemic heart disease, which was confirmed by coronary angiography. Thirteen patients presented with stable effort angina and nine patients with old myocardial infarction. Of these, 18 patients were males and four were females, aged 41 to 74 years (mean 56.2±1.6 years). Patients with resting electrocardiogram (ECG) changes that would make exercise ECG difficult to interpret (ie, conduction disturbances, hypertrophy), were excluded.
For all patients, current medications including anti-ischemic drugs were maintained unchanged during the study, but nitrates were excluded a week before.
Exercise protocol:
All patients performed two maximal, symptomlimited exercise tests (ETs) on the cycloergometer at 24-h intervals (ET1 and ET2), under supervision of the same experienced physician. Both ET1 and ET2 were performed in the morning, according to classical protocols (9,10), in increments of 25 W and 2.5 min duration. One bipolar lead (V5-V5R) was continuously monitored during the tests and was recorded during the last minute of every step and at peak exercise. During the recovery phase, a 12-lead ECG was recorded at 1 min, and every 2 min after, until 9 min or until angina and ECG changes disappeared. ECG was automatically analyzed for ST changes at 0.06 s from the J point. Maximal ST depression was considered in lead V5-V5R during exercise or in the lead with maximum ST depression if that appeared only in the recovery phase. Blood pressure was manually measured by the same pattern as the ECG recording. A test was considered positive if a maximum ST depression of at least 0.1 mV occurred.
The positivity of ET1 represented the including criterion. ET2 was performed after 24 h in similar conditions.
For both ET1 and ET2, the following parameters were analyzed: peak effort (as a measure of maximum systemic oxygen update [VO2max]), heart rate, blood pressure and double product (DP) at peak effort (as a measure of maximum myocardial oxygen demand [peak MVO2]) and maximal ST depression.
Nitrates/nitrites determination:
It has been shown that plasma nitrates or sum of nitrates/nitrites are measures of endogenous NO production (11). Blood samples were obtained for quantitation of nitrates/nitrites before and after each exercise stress test. Post-test samples were obtained during the recovery phase. In order to determine the level of nitrate/nitrite (NOx−), plasma was incubated with reduced nicotinamide adenine dinucleotide phosphate (NADPH) and NADPH-dependent nitrate reductase to convert nitrates to nitrites. Afterwards, the nitrites level was determined by the Griess method (11), using a commercially available analysis kit (Griess Reagent System, Promega Corp, USA) and expressed as μmol/mL. The investigators who performed ETs and NOx− determinations were blinded to the other investigators’ results.
Statistical analysis:
Data were compared before and after every ET or between the two ETs (as necessary) using Student’s paired t test. Data are expressed as mean ± SE. P≤0.05 was considered statistically significant.
RESULTS
The hemodynamic, workload and medication data on the two tests are presented in Table 1. The analysis of the peak effort as a measure of VO2max revealed no significant difference between ET1 and ET2. The mean values of the DP at peak effort, as a measure of peak MVO2, were also very close during ET1 and ET2. Blood pressure and heart rate at peak exercise were identical for both tests (Table 1).
TABLE 1.
Pre-ET1 | Pre-ET2 | P* | Peak ET1 | Peak ET2 | P** | |
---|---|---|---|---|---|---|
sBP (mmHg) | 131±3.5 | 136±3.7 | NS | 170±6.1 | 173±5.7 | NS |
dBP (mmHg) | 84±1.9 | 87±1.8 | NS | 96±2.7 | 101±2.4 | NS |
mBP (mmHg) | 100±2.3 | 104±2.1 | NS | 125±3.4 | 127±2.8 | NS |
HR (min−1) | 72±3.2 | 67±2.5 | 0.01 | 109±6.0 | 103±5.2 | NS |
DP (mmHg/min) | 9474±503 | 9184±498 | NS | 21224±2344 | 22300±2400 | NS |
Workload (W) | – | – | – | 79.3±7.1 | 80.3±7.4 | NS |
Medications expressed as number of patients (percentage): acetylsalicylic acid 22 (100%), beta-blocker 22 (100%), angiotensin-converting enzyme inhibitor 20 (91%), calcium blocker 3 (14%), nitrate 0 (0%).
Comparing pre-ET1 and pre-ET2 values.
Comparing peak ET1 and peak ET2 values. dBP Diastolic blood pressure; DP Double product; ET1 First exercise test; ET2 Second exercise test; HR Heart rate; mBP Mean blood pressure; sBP Systolic blood pressure
In turn, maximal ST depression (Table 2) during ET2 was significantly less than maximal ST depression during ET1, P<0.01. In five patients (22.7%), the ET2 became negative (ST depression less than 1 mm).
TABLE 2.
ET1 | ET2 | P* | |||
---|---|---|---|---|---|
Pre-ET
|
Post-ET
|
Pre-ET
|
Post-ET
|
NS | |
NOx− level (μmol/mL) | 15.38±1.4 | 17.05±1.6 | 15.10±1.3 | 23.65±2.2** | |
ST depression (mm) | 1.73±0.16 | 0.85±0.06 | <0.01 |
Comparing pre-test NOx− level and maximal ST depression at ET1 and ET2.
Significantly higher (P<0.03) versus pre-ET2 value. ET Exercise test; ET1 and ET2 First and second exercise tests, respectively
The plasma NOx− level immediately after ET1 was only slightly higher than rest value before ET1. After 24 h, before ET2, the resting NOx− level was about the same as before ET1. In turn, after ET2, the plasma NOx− level was significantly (P<0.03) higher than both values before ET1 and ET2 (Table 2).
DISCUSSION
Our study shows that the plasma NOx− level increases slightly during ET1 and significantly during ET2, and there is a significant decrease of ST depression during ET2, with peak MVO2 remaining unchanged between the two tests. The attenuation of ECG ischemia during a similar ischemic stress is probably an expression of ischemic preconditioning. Because the protection was observed 24 h after the preconditioning episode, it was attributed to delayed ischemic preconditioning, considering that early preconditioning operates only in the first 2 h after the preconditioning episode (12,13). The observed pattern of evolution of plasma NOx− level is compatible with the theory that NO is a mediator of delayed ischemic preconditioning, alone or together with other mechanisms.
The maximal workload and peak DP during the two consecutive ETs at 24 h were very close. This suggests that training effect or changes of collateral circulation do not influence the parameters reached during ET2 (14).
The contribution of early preconditioning to decreasing maximal ST depression during consecutive exercise testing at 30-min intervals was proved by Tomai et al (15,16) and confirmed by Zdrenghea et al (17). However, studies of delayed preconditioning during consecutive exercise stress testing yielded conflicting results. Two previous studies (4,18) revealed less ST depression during a second ET at 24-h intervals, as in the present study. However, Tomai et al (16) found no delayed protective effect of exercise-induced ischemia.
It was demonstrated experimentally in animals that the preconditioning ischemic episode increases NO production (by eNOS) and other mediators (adenosine, reactive oxygen species) which act synergistically as triggers for the iNOS transcription; the level of the enzyme increases after 24 h and lasts for 72 h (7,8). During this interval of time, a new ischemic episode will result in increased NO production with a decrease of the consequences of myocardial ischemia, the mechanisms of which are only partially known (19,20). However, delayed ischemic preconditioning appears to be a heterogeneous phenomenon, involving multiple inter-related effectors, both NO-dependent and NO-independent (20).
In a recent study (21), nitroglycerin (a NO donor) protected myocardium against PTCA-induced ischemia between 24 h to 72 h after its discontinuation. This supports the hypothesis that NO is not only an effector (as in our study) but also a trigger of delayed ischemic preconditioning.
All clinical studies on preconditioning, including ours, have some inherent limitations because of ethical reasons. Consequently, data are indirect and do not reveal the intimate mechanisms of changes observed.
Given these limitations, we cannot exclude subtle changes of myocardial perfusion from one ET to another, although maximum MVO2 remained relatively unchanged.
In addition, we cannot identify the source of NO by systemic plasma NOx− quantitation. There is evidence that NO can be increased by shear stress, through constitutive NO synthases (22,23), in different cells. These sources of NO could be stimulated by increased perfusion on exercise. However, this does not explain the increase of NOx− only at ET2.
Another problem is that beneficial effect of NO could be exerted not only by mechanisms of preconditioning, but also by ‘classical’ vasodilation, by direct reduction of contractility (24) or by diminishing the norepinephrine release (25).
Finally, the links between the evolution of plasma NOx− and ST changes and between ST changes and ischemic preconditioning are based only on circumstantial evidence, so it is difficult to make a causal relation between them relying solely on these data.
In summary, our study shows an increase of the plasma NO metabolites level after the second of two consecutive exercise stress tests at 24-h intervals, along with a decrease of electrocardiographic consequences of a similar ischemic stress. These findings could be related to delayed ischemic preconditioning, but caution is needed for interpretation.
REFERENCES
- 1.Abete P, Ferrara N, Cacciatore F, et al. High level of physical activity preserves the cardioprotective effect of preinfarction angina in elderly patients. J Am Coll Cardiol. 2001;38:1357–65. doi: 10.1016/s0735-1097(01)01560-1. [DOI] [PubMed] [Google Scholar]
- 2.Kloner RA, Shook T, Przyklenk K, et al. for the TIMI 4 investigators Previous angina alters hospital outcome in TIMI 4. A clinical correlate to preconditioning. Circulation. 1995;91:37–47. doi: 10.1161/01.cir.91.1.37. [DOI] [PubMed] [Google Scholar]
- 3.Noda T, Minatoguchi S, Fujii K, et al. Evidence for the delayed effect in human ischemic preconditioning. Prospective multicenter study for preconditioning in acute myocardial infarction. J Am Coll Cardiol. 1999;34:1966–74. doi: 10.1016/s0735-1097(99)00462-3. [DOI] [PubMed] [Google Scholar]
- 4.Zdrenghea D, Giurgea N, Ilea M, Potâng E. Preconditionarea ischemica tardiva evidentiata prin teste de efort succesive. Revista Româna de Cardiologie. 2000;10:57–60. [Google Scholar]
- 5.Zdrenghea D, Potâng E, Timis D, Bogdan E. Does ischemic preconditioning occur during rehabilitation of ischemic patients? Rom J Intern Med. 1999;37:201–6. [PubMed] [Google Scholar]
- 6.Bolli R, Bhatti ZA, Tang XL, et al. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res. 1997;81:42–52. doi: 10.1161/01.res.81.1.42. [DOI] [PubMed] [Google Scholar]
- 7.Bolli R, Manchikalapudi S, Tang XL, et al. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning. Circ Res. 1997;81:1094–107. doi: 10.1161/01.res.81.6.1094. [DOI] [PubMed] [Google Scholar]
- 8.Guo Y, Jones WK, Xuan Y-T, et al. The late phase of ischemic preconditioning is abrogated by targeted disruption of the iNOS gene. Proc Natl Acad Sci USA. 1999;96:11507–12. doi: 10.1073/pnas.96.20.11507. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Zdrenghea D. In: Testarea de stress în cardiopatia ischemica. Cluj-Napoca RO, editor. Cluj-Napoca: Sincron; 1993. [Google Scholar]
- 10.Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing) Circulation. 2002;106:1883–92. doi: 10.1161/01.cir.0000034670.06526.15. [DOI] [PubMed] [Google Scholar]
- 11.Zeballos GA, Bernstein RD, Thompson CI. Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. Circulation. 1995;91:2982–8. doi: 10.1161/01.cir.91.12.2982. [DOI] [PubMed] [Google Scholar]
- 12.Yellon DM, Baxter GF. A “second window of protection” or delayed preconditioning phenomenon: future horizons for myocardial protection? J Mol Cell Cardiol. 1995;27:1023–34. doi: 10.1016/0022-2828(95)90071-3. [DOI] [PubMed] [Google Scholar]
- 13.Murry CE, Richard VJ, Reimer KA, Jennings RB. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res. 1990;66:913–31. doi: 10.1161/01.res.66.4.913. [DOI] [PubMed] [Google Scholar]
- 14.Zdrenghea D. In: Recuperarea bolnavilor cardiovasculari. Cluj-Napoca RO, editor. Cluj-Napoca: Clusium; 1995. [Google Scholar]
- 15.Tomai F, Crea F, Danesi A, et al. Mechanisms of the warm-up phenomenon. Eur Heart J. 1996;17:1022–7. doi: 10.1093/oxfordjournals.eurheartj.a014997. [DOI] [PubMed] [Google Scholar]
- 16.Tomai F, Perino M, Ghini AS, et al. Exercise-induced myocardial ischemia triggers the early phase of preconditioning but not the late phase. Am J Cardiol. 1999;83:586–8. doi: 10.1016/s0002-9149(98)00918-7. [DOI] [PubMed] [Google Scholar]
- 17.Zdrenghea D, Ilea M, Predescu D, Potâng E. Ischemic preconditioning during successive exercise testing. Rom J Intern Med. 1998;36:161–5. [PubMed] [Google Scholar]
- 18.Bilinska M, Rudnicki S, Beresewicz A. Delayed attenuation of myocardial ischemia with repeated exercise in subjects with stable angina: a possible model for the second window of protection. Basic Res Cardiol. 2000;95:418–23. doi: 10.1007/s003950070042. [DOI] [PubMed] [Google Scholar]
- 19.Rakhit RD, Marber MS. Nitric oxide: an emerging role in cardioprotection? Heart. 2001;86:368–72. doi: 10.1136/heart.86.4.368. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Bolli R. The late phase of preconditioning. Circ Res. 2000;87:972–83. doi: 10.1161/01.res.87.11.972. [DOI] [PubMed] [Google Scholar]
- 21.Leesar MA, Stoddard MF, Dawn B, et al. Delayed preconditioningmimetic action of nitriglycerin in patients undergoing coronary angioplasty. Circulation. 2001;103:2935–41. doi: 10.1161/01.cir.103.24.2935. [DOI] [PubMed] [Google Scholar]
- 22.Hori N, Wiest R, Groszmann RJ. Enhanced release of nitric oxide in response to changes in flow and shear stress in the superior mesenteric arteries of portal hypertensive rats. Hepatology. 1998;28:1467–73. doi: 10.1002/hep.510280604. [DOI] [PubMed] [Google Scholar]
- 23.Papadaki M, Tilton RG, Eskin SG, McIntire LV. Nitric oxide production by cultured human aortic smooth muscle cells: Stimulation by fluid flow. Am J Physiol. 1998;274:H616–26. doi: 10.1152/ajpheart.1998.274.2.h616. [DOI] [PubMed] [Google Scholar]
- 24.Sarkar D, Vallance P, Harding SE. Nitric oxide: Not just a negative inotrope. Eur J Heart Fail. 2001;3:527–34. doi: 10.1016/s1388-9842(01)00163-5. [DOI] [PubMed] [Google Scholar]
- 25.Costa F, Christensen NJ, Farley G, Biaggioni I. NO modulates norepinephrine release in human skeletal muscle: Implications for neural preconditioning. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1494–8. doi: 10.1152/ajpregu.2001.280.5.R1494. [DOI] [PubMed] [Google Scholar]